Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to compare the efficacy and safety of Arotinolol Hydrochloride and Metoprolol succinate on morning blood pressure, heart rate and target organ damage in patients with essential hypertension. To provide evidence for hypertension treatment. A group: Arotinolol Hydrochloride, oral, 5-15mg, bid for 12 weeks. B group: Metoprolol succinate sustained-release tablet, oral, 23.75-71.25mg, qd for 12 weeks.
Epistemonikos ID: cdcef5c2224293f441fa222bb90b0bcb16ae8a31
First added on: May 12, 2024